Shenglei Li

782 total citations
35 papers, 592 citations indexed

About

Shenglei Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shenglei Li has authored 35 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Shenglei Li's work include RNA modifications and cancer (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Shenglei Li is often cited by papers focused on RNA modifications and cancer (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Shenglei Li collaborates with scholars based in China. Shenglei Li's co-authors include Tianli Fan, Hongtao Liu, Jianping Yang, Xianzheng Gao, Yilin Xie, Dandan Zhang, Hui Zhao, Xin Wang, Ning Wang and Hongtao Liu and has published in prestigious journals such as Journal of Cellular Physiology, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Shenglei Li

35 papers receiving 586 citations

Peers

Shenglei Li
Qicong Luo China
Shaobin Wu China
Lijie He China
Walid Chemlali France
Antonella Federico Italy
Wen-jing Wu China
Suhua Xia China
Dianqi Xin China
Cristina Sáiz-Ladera Spain
Qicong Luo China
Shenglei Li
Citations per year, relative to Shenglei Li Shenglei Li (= 1×) peers Qicong Luo

Countries citing papers authored by Shenglei Li

Since Specialization
Citations

This map shows the geographic impact of Shenglei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglei Li more than expected).

Fields of papers citing papers by Shenglei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglei Li. The network helps show where Shenglei Li may publish in the future.

Co-authorship network of co-authors of Shenglei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglei Li. A scholar is included among the top collaborators of Shenglei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglei Li. Shenglei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Fangxia, Shenglei Li, Qing Zhang, et al.. (2024). Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1. Molecular Carcinogenesis. 63(5). 897–911. 5 indexed citations
2.
Wei, Na, Luoman Zhang, Jingjing Xu, et al.. (2024). Astaxanthin Rescues Memory Impairments in Rats with Vascular Dementia by Protecting Against Neuronal Death in the Hippocampus. NeuroMolecular Medicine. 26(1). 29–29. 4 indexed citations
3.
Liu, Donglin, Xudong Zhang, Mingzhi Zhang, et al.. (2023). MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients. Cancer Medicine. 12(18). 18568–18577. 1 indexed citations
4.
Li, Yan, Kunlun Wang, Erjiang Zhao, et al.. (2022). Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma. Pathology & Oncology Research. 28. 1610245–1610245. 9 indexed citations
5.
Zhao, Huayan, Shenglei Li, Guannan Wang, et al.. (2019). Study of the mechanism by which dinaciclib induces apoptosis and cell cycle arrest of lymphoma Raji cells through a CDK1‐involved pathway. Cancer Medicine. 8(9). 4348–4358. 29 indexed citations
6.
Gao, Xianzheng, Guan‐Nan Wang, Wugan Zhao, et al.. (2019). Blocking OLFM4/HIF‐1α axis alleviates hypoxia‐induced invasion, epithelial–mesenchymal transition, and chemotherapy resistance in non‐small‐cell lung cancer. Journal of Cellular Physiology. 234(9). 15035–15043. 20 indexed citations
7.
Liu, Hongtao, Qing Zhang, Xin Zhang, et al.. (2019). Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer. Pathology & Oncology Research. 26(2). 1029–1039. 61 indexed citations
8.
Wang, Jiaojiao, Lijie Song, Sen Yang, et al.. (2017). HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma-not otherwise specified. Molecular Medicine Reports. 16(4). 4634–4642. 7 indexed citations
9.
Li, Shenglei, Yunhui Qu, Xiaoqi Chen, et al.. (2016). HDAC2 regulates cell proliferation, cell cycle progression and cell apoptosis in esophageal squamous cell carcinoma EC9706 cells. Oncology Letters. 13(1). 403–409. 35 indexed citations
10.
Gao, Ming, Liying Liu, Shenglei Li, et al.. (2015). Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42. Oncology Reports. 34(5). 2523–2532. 16 indexed citations
11.
12.
Liu, Hongchun, et al.. (2014). TPX2 siRNA regulates growth and invasion of esophageal cancer cells. Biomedicine & Pharmacotherapy. 68(7). 833–839. 21 indexed citations
13.
Li, Shenglei, et al.. (2013). Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma. Tumor Biology. 34(6). 4089–4100. 40 indexed citations
14.
Zhao, Hui, Jianping Yang, Tianli Fan, Shenglei Li, & Xuequn Ren. (2012). RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway. Tumor Biology. 33(5). 1363–1374. 46 indexed citations
15.
16.
17.
Wang, Feng, Shenglei Li, Ke Li, et al.. (2011). Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. Journal of Surgical Oncology. 103(7). 704–715. 12 indexed citations
18.
Liu, Hongtao, Ning Wang, Xin Wang, & Shenglei Li. (2010). Overexpression of Pim‐1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Journal of Surgical Oncology. 102(6). 683–688. 37 indexed citations
19.
Zhang, Qiao, et al.. (2009). Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues. Journal of Cancer Research and Clinical Oncology. 136(4). 587–594. 17 indexed citations
20.
Zhao, Weixing, et al.. (2002). [Association of p53, PCNA expression and trace element content in esophageal mucosa].. PubMed. 21(7). 757–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qicong Luo Breakdown of academic impact, for papers by Shaobin Wu Breakdown of academic impact, for papers by Lijie He Breakdown of academic impact, for papers by Walid Chemlali Breakdown of academic impact, for papers by Antonella Federico Breakdown of academic impact, for papers by Wen-jing Wu Breakdown of academic impact, for papers by Suhua Xia Breakdown of academic impact, for papers by Dianqi Xin Breakdown of academic impact, for papers by Cristina Sáiz-Ladera
Rankless by CCL
2026